Unveiling HMPV: The Overlooked Respiratory Threat

Human Metapneumovirus (HMPV) is a significant respiratory virus gaining attention following outbreaks in China and India. Symptoms vary from mild cold-like effects to severe pneumonia, particularly affecting vulnerable groups. There is no specific treatment or vaccine yet, and preventive measures and supportive care are recommended.

Human Metapneumovirus (HMPV), a respiratory virus, has recently been spotlighted after cases emerged in India and China. Although first discovered in 2001, it has shown a capacity to cause significant public health concerns.

The virus transmits via respiratory droplets and affects individuals of all ages, with particularly severe consequences for infants, elders, and those with weakened immune systems. Except for general hygienic practices, no specific antiviral treatments or vaccines are yet available for HMPV.

The Indian Council of Medical Research's vigilant monitoring and surveillance help track such respiratory illnesses, emphasizing the importance of a robust healthcare infrastructure in mitigating potential outbreaks.

(With inputs from agencies.)